Technical Analysis for NUVA - NuVasive, Inc.

Grade Last Price % Change Price Change
grade C 56.9 1.61% 0.90
NUVA closed up 1.61 percent on Monday, March 25, 2019, on 32 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical NUVA trend table...

Date Alert Name Type % Chg
Mar 22 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 1.61%
Mar 22 Inside Day Range Contraction 1.61%
Mar 21 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.39%
Mar 21 Outside Day Range Expansion 0.39%
Mar 20 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 2.82%
Mar 20 Calm After Storm Range Contraction 2.82%
Mar 20 Narrow Range Bar Range Contraction 2.82%
Mar 20 Inside Day Range Contraction 2.82%
Mar 19 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 1.95%
Mar 19 Calm After Storm Range Contraction 1.95%

Older signals for NUVA ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
NuVasive, Inc., a medical device company, engages in the design, development, and marketing of minimally disruptive surgical products and procedurally integrated solutions for the spine. The company's products focus on applications for spine fusion surgery. It offers products for the thoracolumbar spine and the cervical spine primarily used to enable access to the spine and to perform restorative and fusion procedures in a minimally disruptive fashion. The company's principal products include a minimally disruptive surgical platform called Maximum Access Surgery (MAS), as well as cervical, biologics, and motion preservation products. Its MAS platform combines three categories of product offerings, including NVM5 and NVJJB, its proprietary software-driven nerve detection and avoidance systems, and intra-operative monitoring support services for insight into the nervous system during spine and other surgeries; MaXcess, an integrated split-blade retractor system; and various specialized implants. The company's biologic products include allograft, a donated human tissue; FormaGraft, a collagen synthetic product; Osteocel Plus, an allograft cellular matrix containing viable mesenchymal stem cells; and AttraX, a synthetic bone graft material. It also offers solutions for cervical fusion surgery, including allograft and CoRoent implants, as well as cervical plating and posterior fixation products. In addition, the company's products comprise PCM device, a motion preserving total disc replacement device; and XL TDR, a mechanical total disc replacement solution. NuVasive, Inc. sells its products through directly-employed sales shareowners, independent sales agents, and distributors to surgeons and hospitals in the United States and internationally. The company was founded in 1997 and is headquartered in San Diego, California.
Medicine Surgery Stem Cells Neurosurgery Surgeries Biologic Products Spinal Fusion Transplantation Medicine Allotransplantation Bone Grafting Neurosurgical Procedures Intervertebral Disc Arthroplasty
Is NUVA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 72.41
52 Week Low 43.51
Average Volume 830,636
200-Day Moving Average 58.6389
50-Day Moving Average 53.7422
20-Day Moving Average 57.156
10-Day Moving Average 55.747
Average True Range 1.9422
ADX 17.74
+DI 14.9323
-DI 17.493
Chandelier Exit (Long, 3 ATRs ) 54.0034
Chandelier Exit (Short, 3 ATRs ) 59.3866
Upper Bollinger Band 60.1194
Lower Bollinger Band 54.1926
Percent B (%b) 0.46
BandWidth 10.369515
MACD Line 0.2753
MACD Signal Line 0.5773
MACD Histogram -0.302
Fundamentals Value
Market Cap 2.89 Billion
Num Shares 50.8 Million
EPS 0.63
Price-to-Earnings (P/E) Ratio 90.32
Price-to-Sales 2.91
Price-to-Book 4.32
PEG Ratio 2.15
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 59.23
Resistance 3 (R3) 59.02 58.04 58.84
Resistance 2 (R2) 58.04 57.45 58.14 58.71
Resistance 1 (R1) 57.47 57.08 57.76 57.68 58.58
Pivot Point 56.49 56.49 56.63 56.59 56.49
Support 1 (S1) 55.92 55.90 56.21 56.13 55.22
Support 2 (S2) 54.94 55.53 55.04 55.09
Support 3 (S3) 54.37 54.94 54.96
Support 4 (S4) 54.58